To enable high-quality and timely decision making in CNS drug development, we specialise in the development of evidence-based experimental medicine tools that support early, low cost, biomarker-inspired proof-of-mechanism and/or proof-of-concept studies of target compounds.
Our innovative products include:
P1vital® ePRO Clinical is a flexible, digital solution designed to automatically prompt, curate, and store securely clinical study data from study participants and researchers
The P1vital® fMRI system has been used in functional MRI clinical trials by the pharmaceutical industry for over 10 years to help understand how novel compounds for treating CNS Disorders such as schizophrenia and depression affect brain function.
The P1vital® ETB has been used in clinical trials by the pharmaceutical industry for over 10 years, to provide an early indication of the effectiveness of novel compounds in treating mood disorders such as depression.